These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7545526)

  • 1. Selection of more pathogenic hepatitis C virus genotype II during long-term follow-up of interferon-treated patients.
    Villa E; Buttafoco P; Merighi A; Grottola A; Ferretti I; Ferrari A; Callea F; Trande P; Rebecchi AM; Manenti F
    J Mol Med (Berl); 1995 May; 73(5):249-54. PubMed ID: 7545526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.
    Hino K; Sainokami S; Shimoda K; Iino S; Wang Y; Okamoto H; Miyakawa Y; Mayumi M
    J Med Virol; 1994 Mar; 42(3):299-305. PubMed ID: 7516422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis.
    Magrin S; Craxì A; Fabiano C; Fiorentino G; Marino L; Almasio P; Pinzello GB; Palazzo U; Vitale M; Maggio A
    J Med Virol; 1992 Nov; 38(3):200-6. PubMed ID: 1283753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C.
    Aiyama T; Yoshioka K; Hirofuji H; Kusakabe A; Yamada M; Tanaka K; Kakumu S
    Dig Dis Sci; 1994 Oct; 39(10):2244-9. PubMed ID: 7924750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.
    Nousbaum JB; Pol S; Nalpas B; Landais P; Berthelot P; Bréchot C
    Ann Intern Med; 1995 Feb; 122(3):161-8. PubMed ID: 7810932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis.
    Saracco G; Abate ML; Baldi M; Calvo PL; Manzini P; Brunetto MR; Oliveri F; Kuo G; Chien D; Houghton M
    Liver; 1994 Apr; 14(2):65-70. PubMed ID: 7515141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to interferon in chronic hepatitis C due to mixed genotype infection.
    Horiike N; Masumoto T; Michitaka K; Kurose K; Akbar SM; Onji M
    J Gastroenterol Hepatol; 1996 Apr; 11(4):353-7. PubMed ID: 8713702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy.
    Suzuki T; Tanaka E; Matsumoto A; Urushihara A; Sodeyama T
    J Med Virol; 1995 Jun; 46(2):162-8. PubMed ID: 7636506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C. Evaluation of HCV genotypes during and after long-term follow-up.
    Diodati G; Bonetti P; Tagger A; Casarin C; Noventa F; Ribero M; Fasola M; Ruol A; Realdi G
    Dig Dis Sci; 1994 Nov; 39(11):2497-502. PubMed ID: 7525169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon treatment for chronic hepatitis C infection in hemophiliacs--influence of virus load, genotype, and liver pathology on response.
    Hanley JP; Jarvis LM; Andrew J; Dennis R; Hayes PC; Piris J; Lee R; Simmonds P; Ludlam CA
    Blood; 1996 Mar; 87(5):1704-9. PubMed ID: 8634415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus RNA and long-term response to recombinant interferon-alpha 2b in patients with chronic hepatitis C.
    Tanno H; Fernández JL; Rendo P; del Pino N; Viola L; Terg R; Pérez V
    J Viral Hepat; 1995; 2(2):97-102. PubMed ID: 7493304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in antibody titers to hepatitis C virus following interferon therapy for chronic infection.
    Urushihara A; Sodeyama T; Matsumoto A; Tanaka E
    J Med Virol; 1994 Apr; 42(4):348-56. PubMed ID: 7519250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Titration and genotyping of hepatitis C virus RNA in chronic hepatitis C patients treated with interferon].
    Konishi M
    Nihon Shokakibyo Gakkai Zasshi; 1994 Feb; 91(2):147-53. PubMed ID: 8114320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha.
    Löhr HF; Elste C; Dienes HP; Michel G; Braun HB; Meyer zum Büschenfelde KH; Gerken G
    J Hepatol; 1996 Sep; 25(3):292-300. PubMed ID: 8895007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon therapy in chronic hepatitis C virus: evidence of different outcome with respect to different viral strains.
    Pozzato G; Moretti M; Crocé LS; Sasso F; Kaneko S; Unoura M; Kobayashi K; Crovatto M; Santini G; Tiribelli C
    J Med Virol; 1995 Apr; 45(4):445-50. PubMed ID: 7666045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of HCV antibodies with special reference to NS5A reactivity in HCV-infected patients: relation to viral genotype, cryoglobulinemia and response to interferon.
    Frangeul L; Cresta P; Perrin M; Duverlie G; Khorsi H; Musset L; Opolon P; Huraux JM; Lunel F
    J Hepatol; 1998 Apr; 28(4):538-43. PubMed ID: 9566820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypes of hepatitis C virus in relapsed and non-respondent patients and their response to anti-viral therapy in district Mardan, Khyber Pakhtunkhawa, Pakistan.
    Akhtar N; Bilal M; Rizwan M; Khan MA; Khan A
    Asian Pac J Cancer Prev; 2015; 16(3):1037-40. PubMed ID: 25735327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical value of grading and staging scores for predicting a long-term response and evaluating the efficacy of interferon therapy in chronic hepatitis C.
    Shindo M; Arai K; Okuno T
    J Hepatol; 1997 Mar; 26(3):492-7. PubMed ID: 9075654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes.
    Hopf U; Berg T; König V; Küther S; Heuft HG; Lobeck H
    J Hepatol; 1996; 24(2 Suppl):67-73. PubMed ID: 8836892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of interferons in treating children with chronic hepatitis C.
    Matsuoka S; Mori K; Nakano O; Yuasa Y; Taguchi Y; Hayabuchi Y; Kuroda Y
    Eur J Pediatr; 1997 Sep; 156(9):704-8. PubMed ID: 9296534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.